SIST ISO 22441:2024 PDF
Sterilization of health care products - Low temperature vaporized hydrogen peroxide -- Requirements for the development, validation and routine control of a sterilization process for medical devices (ISO 22441:2022)
Sterilization of health care products - Low temperature vaporized hydrogen peroxide -- Requirements for the development, validation and routine control of a sterilization process for medical devices (ISO 22441:2022)
- Статус документа:
- Действующий
- Формат:
- Электронный (PDF)
- Количество страниц:
- 87
- Дата публикации:
- 23 апреля 2024 г.
- Издание:
- ISO 22441:2022
- ICS:
- 11.080.01
1.1 Inclusions 1.1.1 This document provides requirements for the development, validation and routine monitoring and control of a low temperature sterilization process for medical devices using vaporized hydrogen peroxide (VH2O2) as the sterilizing agent. 1.1.2 This document is intended to be applied by process developers, manufacturers of sterilization equipment, manufacturers of medical devices to be sterilized, organizations performing process validation of VH2O2 sterilization, and organizations responsible for sterilizing medical devices. NOTE VH2O2 sterilizers can be used in both health care and industrial facilities, and this document acknowledges the similarities and differences between the two applications. 1.2 Exclusions 1.2.1 Processes that use other sterilizing agents, or hydrogen peroxide solution in combination with other chemicals as the sterilizing agent are not addressed in this document. NOTE See ISO 14937 for guidance on validation of such processes. 1.2.2 This document does not specify requirements for development, validation and routine control of a process for inactivating the causative agents of spongiform encephalopathies, e.g. scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. Specific recommendations have been produced in particular countries for the processing of materials potentially contaminated with these agents. NOTE Some VH2O2 sterilizers have processes that demonstrate some level of inactivation of the causative agents of spongiform encephalopathies, e.g. scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob Disease. However, this inactivation is process, cycle, and test protocol specific, therefore this inactivation is outside the scope of this document, and no specific test methods are provided (see [14], [26], and [30] for more information). 1.2.3 This document does not specify requirements for designating a medical device as sterile. NOTE See for example EN 556–1 or ANSI/AAMI ST67. 1.2.4 This document does not specify requirements for occupational safety associated with the design and operation of VH2O2 sterilization equipment. NOTE For further information on safety, see examples in the Bibliography. National or regional regulations can also exist. 1.2.5 This document does not apply to the contents of contained product, i.e. product for which the environment within the sterilizer chamber during any stage of the sterilization process does not come into direct contact with the product, such as a solution in a sealed bottle. 1.2.6 This document does not cover hydrogen peroxide decontamination systems for use in rooms, enclosures or environmental spaces. NOTE These decontamination systems operate at ambient conditions (e.g. temperature and pressure) and in general utilise an approach that is different to that of VH2O2 sterilization processes addressed in this document.
Abstract
Overview
SIST ISO 22441:2024 specifies requirements for the development, validation and routine monitoring/control of low temperature sterilization processes that use vaporized hydrogen peroxide (VH2O2) as the sterilizing agent. Designed primarily for thermolabile and moisture‑sensitive medical devices, VH2O2 sterilizers generally operate at temperatures typically below 60 °C and are used in both health‑care and industrial settings. The standard describes a framework that ensures sterilization processes are effective, reproducible and compatible with quality management systems.
Key technical topics and requirements
- Process development and definition
- Selection of process parameters and cycle design for VH2O2 sterilization.
- Consideration of product definition, packaging and sterilizer interaction.
- Sterilant characterization
- Properties and microbicidal effectiveness of vaporized hydrogen peroxide, and material compatibility.
- Validation lifecycle
- Installation Qualification (IQ), Operational Qualification (OQ) and Performance Qualification (PQ).
- Annexed approaches for process definition: bioburden method, BI/bioburden method and overkill method.
- Routine monitoring and control
- Requirements for ongoing performance control, biological indicators (BIs), temperature sensors and other routine checks.
- Quality management integration
- Supporting guidance
- Informative annexes on cycle examples, environmental aspects, recommended tests and test procedures.
- Explicit exclusions
- Processes using other sterilants or combined chemistries, prion inactivation guidance, designation of sterile devices, occupational safety design, sealed contained products and room decontamination systems.
Practical applications - who uses SIST ISO 22441:2024
- Process developers creating VH2O2 sterilization cycles.
- Manufacturers of sterilization equipment and VH2O2 sterilizers.
- Medical device manufacturers who need validated, low‑temperature sterilization for devices and packaging.
- Contract sterilization and validation laboratories performing IQ/OQ/PQ and routine control.
- Healthcare facilities operating VH2O2 sterilizers for reusable instruments and sensitive devices.
Benefits include standardized validation practices, clearer product/process definitions, improved reproducibility and support for regulatory compliance.
Related standards and references
- ISO 14937 - guidance for validation of other sterilization processes.
- ISO 17664-1 - processing information for sterilization of medical devices.
- EN 556-1, ANSI/AAMI ST67 - designation and requirements for sterile medical devices.
- ISO 13485 / ISO 9001 - quality management system context.
- EN 17180 - VH2O2 sterilizer requirements (under development).
Keywords: SIST ISO 22441:2024, VH2O2 sterilization, vaporized hydrogen peroxide, low temperature sterilization, medical device sterilization, sterilization validation, IQ OQ PQ, bioburden, biological indicators.
Технические детали
- Технический комитет
- VAZ - Healthcare
- SKU
- SIST ISO 22441:2024
Похожие стандарты
Стандарты, упомянутые в описании
ISO 19443:2018/Amd 1:2024
ДействующийQuality management systems — Specific requirements for the application of ISO 9001:2015 by organizations in t…
Overview ISO 19443:2018/Amd 1:2024 is an important amendment to the ISO 19443:2018 standard, which specifies quality management system requirements tailored for organizations within the supply chain…
SIST EN ISO 13485:2016/A11:2021
ДействующийMedical devices - Quality management systems - Requirements for regulatory purposes (ISO 13485:2016)
Overview EN ISO 13485:2016/A11:2021 is the European amendment (A11) to the international standard ISO 13485:2016 specifying quality management system (QMS) requirements for medical devices. Prepared…
SIST EN ISO 14937:2010
ДействующийSterilization of health care products - General requirements for characterization of a sterilizing agent and…
Overview EN ISO 14937:2009 (ISO 14937:2009) - "Sterilization of health care products" - sets out general requirements for characterization of a sterilizing agent and for the development, validation a…
SIST EN ISO 17664-1:2021
ДействующийProcessing of health care products - Information to be provided by the medical device manufacturer for the pr…
Overview - EN ISO 17664-1:2021 (Processing medical devices) EN ISO 17664-1:2021 specifies the information that medical device manufacturers must provide to support safe and effective processing of cr…